On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
Reminder: On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the ch...
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...